EPISODE · Apr 12, 2021 · 9 MIN
NMSS Partnership Targets Autoimmune Disease Research
from MS News & Perspectives · host MS News Today
Multiple Sclerosis News Today’s columnist, Jenn Powell, discusses a NMSS partnership which targets autoimmune disease research.Multiple Sclerosis News Today’s columnist, Jessie Ace discusses how MS makes her feel part of a secret club of a minority who understand.=====================================Treatment for Relapsing MS Progression | MAYZENT® (siponimod)Read about MAYZENT, a once daily pill that can significantly slow down disability progression in people with relapsing MS. See full prescribing & safety info. https://www.mayzent.com/?utm_source=changeinrms&utm_medium=vanityurl&utm_campaign=novartis_mayzent_2020&utm_content=soundcloud ===================================== Are you interested in learning more about multiple sclerosis? If so, please visit:https://multiplesclerosisnewstoday.com/ =====================================To join in on conversations regarding multiple sclerosis, please visit:https://multiplesclerosisnewstoday.com/forums/
Embed this episode
NOW PLAYING
NMSS Partnership Targets Autoimmune Disease Research
No transcript for this episode yet
Similar Episodes
No similar episodes found.
Similar Podcasts
No similar podcasts found.